4 completed, 2 unknown. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Unknown 2 |
| Phase 2 | 1 | Completed 1 |
Follow bilastine: new trials by email Literature Review of bilastine trials Research Report on bilastine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions Bilastine oral dispersible tablets, Bilaxten oral dispersible tablets - Allergic Rhino-Conjunctivitis, Urticaria | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 42 | 2025-04-30 | 2025-06-29 |
| Bioequivalence Study of Bilastine Tablets in Healthy Chinese Subjects Test (T) Bilastine, Reference (R) Bilastine - Healthy | Phase 1 | Unknown | The Affiliated Hospital of Qingdao University | 40 | 2023-11-21 | 2023-10-24 |
| Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese Population Bilastine 40mg single dose, Bilastine 20mg single-dose followed by multiple-dose - Pharmacokinetics | Phase 1 | Unknown | A.Menarini Asia-Pacific Holdings Pte Ltd | 24 | 2018-08-28 | 2019-01-10 |
| Oral Bioavailability of Bilastine Bilastine - Healthy | Phase 1 | Completed | Faes Farma, S.A. | 12 | 2010-05-01 | 2012-09-26 |
| Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) Bilastine - Allergic Rhinoconjunctivitis, Chronic Urticaria | Phase 1 / Phase 2 | Completed | Faes Farma, S.A. | 36 | 2010-01-01 | 2012-09-26 |
| A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine bilastine, Bilastine, Bilastine & Ketoconazole - Healthy | Phase 1 | Completed | Faes Farma, S.A. | 30 | 2006-08-01 | 2012-04-05 |
Urticaria (3) · Rhinitis, Allergic (2) · Chronic Urticaria (1) · Erythema (1) · Hypersensitivity (1) · Nasal Obstruction (1) · Pruritus (1) · Rhinitis, Allergic, Perennial (1) · Rhinitis, Allergic, Seasonal (1) · Rhinorrhea (1) · Sneezing (1)
Faes Farma, S.A. (3) · A.Menarini Asia-Pacific Holdings Pte Ltd (1) · Humanis Saglık Anonim Sirketi (1) · The Affiliated Hospital of Qingdao University (1)
Australia (1) · China (1) · Germany (1) · India (1) · Spain (1) · Sweden (1) · United States (1)
Andrea Luk, Professor (1) · Belen Sadaba, MD (1) · Gunilla Hedlin, Prof. Dr. (1) · Lennart Nordvall, Prof. Dr (1) · Mark J Allison, MD (1) · Noel E Cranswick, Prof. Dr. (1) · Peter Le Souef, Prof. Dr. (1) · Stefan Zielen, Prof. Dr. (1) · Ulrich Wahn, Prof. Dr. (1)
PMID 21642470, PMID 22393898, PMID 23529786
2009 (1)